Ledger.Open graph →
SEC Form D · filed June 6, 2014

Spark Therapeutics, Inc

Offering
$72.8M
Sold
$72.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Joseph W. La Barge · Philadelphia, PAExecElliott M. Sigal · Philadelphia, PADirectorRogerio M. Vivaldi · Philadelphia, PADirectorArthur M. Dantchik · Philadelphia, PADirectorLars M. Ekman, M.D. Ph.D · Philadelphia, PADirectorSteven M. Altschuler · Philadelphia, PADirectorJeffrey D. Marrazzo · Philadelphia, PAExec · DirectorAnand M. Mehra · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗